DESMOPRESSIN ACETATE

Desmopressin Acetate Adverse Events Reported to the FDA Over Time

How are Desmopressin Acetate adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Desmopressin Acetate, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Desmopressin Acetate is flagged as the suspect drug causing the adverse event.

Most Common Desmopressin Acetate Adverse Events Reported to the FDA

What are the most common Desmopressin Acetate adverse events reported to the FDA?

Hyponatraemia	289 (7.38%)
Convulsion	108 (2.76%)
Vomiting	87 (2.22%)
Drug Ineffective	85 (2.17%)
Nausea	75 (1.91%)
Headache	71 (1.81%)
Confusional State	65 (1.66%)
Fall	53 (1.35%)
Blood Sodium Decreased	50 (1.28%)
Water Intoxication	44 (1.12%)
Drug Interaction	43 (1.1%)
	Show More
Loss Of Consciousness	40 (1.02%)
Coma	39 (1%)
Dizziness	38 (.97%)
Overdose	38 (.97%)
Off Label Use	37 (.94%)
Brain Oedema	35 (.89%)
Abdominal Pain	34 (.87%)
Drug Effect Decreased	31 (.79%)
Pyrexia	30 (.77%)
Hypernatraemia	29 (.74%)
Hypokalaemia	29 (.74%)
Hallucination	27 (.69%)
Inappropriate Antidiuretic Hormone ...	27 (.69%)
Agitation	25 (.64%)
Disorientation	25 (.64%)
Malaise	24 (.61%)
Dyspnoea	23 (.59%)
Medication Error	23 (.59%)
Grand Mal Convulsion	22 (.56%)
Lethargy	22 (.56%)
Epilepsy	21 (.54%)
Pain	21 (.54%)
Thirst	21 (.54%)
Diarrhoea	20 (.51%)
Electrolyte Imbalance	20 (.51%)
Fatigue	20 (.51%)
Condition Aggravated	19 (.49%)
Flushing	19 (.49%)
Dehydration	18 (.46%)
Hypotension	18 (.46%)
Depressed Level Of Consciousness	17 (.43%)
Psychotic Disorder	17 (.43%)
Amnesia	16 (.41%)
Asthenia	16 (.41%)
Balance Disorder	16 (.41%)
Depression	15 (.38%)
Hypertension	15 (.38%)
Myocardial Infarction	15 (.38%)
Petechiae	15 (.38%)
Pollakiuria	15 (.38%)
Tremor	15 (.38%)
Anorexia	14 (.36%)
Blood Pressure Increased	14 (.36%)
Chills	14 (.36%)
Pulmonary Embolism	14 (.36%)
Incorrect Dose Administered	13 (.33%)
Somnolence	13 (.33%)
Blood Creatine Phosphokinase Increa...	12 (.31%)
Chest Discomfort	12 (.31%)
Dry Mouth	12 (.31%)
Hyperhidrosis	12 (.31%)
Intestinal Ischaemia	12 (.31%)
Rash	12 (.31%)
Rhabdomyolysis	12 (.31%)
Therapeutic Response Unexpected Wit...	12 (.31%)
Urine Output Increased	12 (.31%)
Disturbance In Attention	11 (.28%)
Incontinence	11 (.28%)
Vision Blurred	11 (.28%)
Abdominal Pain Upper	10 (.26%)
Abnormal Behaviour	10 (.26%)
Anxiety	10 (.26%)
Bladder Cancer	10 (.26%)
Blood Potassium Decreased	10 (.26%)
Blood Sodium Increased	10 (.26%)
Diabetes Insipidus	10 (.26%)
Epistaxis	10 (.26%)
Hyperacusis	10 (.26%)
Memory Impairment	10 (.26%)
Migraine	10 (.26%)
Oedema Peripheral	10 (.26%)
Weight Increased	10 (.26%)
Arterial Thrombosis	9 (.23%)
Cerebrovascular Accident	9 (.23%)
Chest Pain	9 (.23%)
Eye Infection	9 (.23%)
Kidney Infection	9 (.23%)
Muscular Weakness	9 (.23%)
Restlessness	9 (.23%)
Sleep Terror	9 (.23%)
Thrombosis	9 (.23%)
Vena Cava Thrombosis	9 (.23%)
Aggression	8 (.2%)
Altered State Of Consciousness	8 (.2%)
Blood Chloride Decreased	8 (.2%)
Blood Osmolarity Decreased	8 (.2%)
Blood Pressure Decreased	8 (.2%)
Cognitive Disorder	8 (.2%)
Constipation	8 (.2%)
Deep Vein Thrombosis	8 (.2%)

Share/Embed Graph Export Data

This graph shows the top adverse events submitted to the FDA for Desmopressin Acetate, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Desmopressin Acetate is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Desmopressin Acetate

What are the most common Desmopressin Acetate adverse events reported to the FDA?

Electrolyte And Fluid Balance Condi...	458 (11.69%)
Neurological	275 (7.02%)
Gastrointestinal Signs	226 (5.77%)
Therapeutic And Nontherapeutic Effe...	187 (4.77%)
Seizures	162 (4.14%)
Medication Errors	111 (2.83%)
Water, Electrolyte And Mineral	110 (2.81%)
Deliria	93 (2.37%)
Headaches	81 (2.07%)
Injuries	78 (1.99%)
Infections - Pathogen Unspecified	58 (1.48%)
	Show More
Respiratory	58 (1.48%)
Urinary Tract Signs	54 (1.38%)
Mental Impairment	50 (1.28%)
Muscle	49 (1.25%)
Epidermal And Dermal Conditions	47 (1.2%)
Therapeutic Procedures And Supporti...	47 (1.2%)
Hypothalamus And Pituitary Gland	44 (1.12%)
Cardiac And Vascular Investigations	43 (1.1%)
Increased Intracranial Pressure And...	43 (1.1%)
Anxiety Disorders	42 (1.07%)
Hematology Investigations	41 (1.05%)
Renal And Urinary Tract Investigati...	41 (1.05%)
Cardiac Arrhythmias	38 (.97%)
Disturbances In Thinking	37 (.94%)
Embolism And Thrombosis	37 (.94%)
Body Temperature Conditions	36 (.92%)
Gastrointestinal Motility And Defec...	33 (.84%)
Coronary Artery	32 (.82%)
Hepatic And Hepatobiliary	31 (.79%)
Renal Disorders	31 (.79%)
Decreased And Nonspecific Blood Pre...	29 (.74%)
Vascular	27 (.69%)
Vision	26 (.66%)
Central Nervous System Vascular	25 (.64%)
Movement Disorders	25 (.64%)
Hepatobiliary	23 (.59%)
Enzyme	21 (.54%)
Physical Examination Topics	21 (.54%)
Procedural And Device Related Injur...	21 (.54%)
Appetite And General Nutritional	19 (.49%)
Renal And Urinary Tract Neoplasms M...	18 (.46%)
Skin Vascular Abnormalities	18 (.46%)
Arteriosclerosis, Stenosis, Vascula...	17 (.43%)
Cardiac Disorder Signs	17 (.43%)
Schizophrenia And Other Psychotic	17 (.43%)
Depressed Mood Disorders	16 (.41%)
Upper Respiratory Tract Disorders	16 (.41%)
Hearing	15 (.38%)
Personality Disorders	15 (.38%)
Skin Appendage Conditions	15 (.38%)
Vascular Hypertensive	15 (.38%)
Allergic Conditions	14 (.36%)
Bacterial Infectious	14 (.36%)
Gastrointestinal Vascular Condition...	14 (.36%)
Myocardial	14 (.36%)
Pulmonary Vascular	14 (.36%)
Changes In Physical Activity	13 (.33%)
Encephalopathies	13 (.33%)
Salivary Gland Conditions	13 (.33%)
Oral Soft Tissue Conditions	12 (.31%)
Sleep Disorders	12 (.31%)
Heart Failures	11 (.28%)
Lifestyle Issues	11 (.28%)
Metabolic, Nutritional And Blood Ga...	11 (.28%)
Psychiatric	11 (.28%)
Chemical Injury And Poisoning	10 (.26%)
Ocular Neuromuscular	10 (.26%)
Platelet	10 (.26%)
Psychiatric And Behavioural Symptom...	10 (.26%)
Suicidal And Self-injurious Behavio...	10 (.26%)
Vascular Hemorrhagic	10 (.26%)
Angiedema And Urticaria	9 (.23%)
Bone, Calcium, Magnesium And Phosph...	9 (.23%)
Gallbladder	9 (.23%)
Inner Ear And Viiith Cranial Nerve	9 (.23%)
Mood Disorders	9 (.23%)
Peritoneal And Retroperitoneal Cond...	9 (.23%)
Product Quality Issues	9 (.23%)
Anemias Nonhemolytic And Marrow Dep...	8 (.2%)
Bone And Joint Injuries	8 (.2%)
Cranial Nerve Disorders	8 (.2%)
Demyelinating	8 (.2%)
Glucose Metabolism Disorders	8 (.2%)
Joint	8 (.2%)
Musculoskeletal And Connective Tiss...	8 (.2%)
Gastrointestinal Inflammatory Condi...	7 (.18%)
Hemolyses And Related Conditions	7 (.18%)
Miscellaneous And Site Unspecified ...	7 (.18%)
Neurological Disorders Of The Eye	7 (.18%)
Tongue Conditions	7 (.18%)
White Blood Cell	7 (.18%)
Administration Site Reactions	6 (.15%)
Coagulopathies And Bleeding Diathes...	6 (.15%)
Communication Disorders	6 (.15%)
Fatal Outcomes	6 (.15%)
Lipid Metabolism	6 (.15%)
Lower Respiratory Tract Disorders	6 (.15%)
Pericardial	6 (.15%)
Spleen, Lymphatic And Reticulendoth...	6 (.15%)
Adrenal Gland	5 (.13%)

Share/Embed Graph Export Data

This graph shows the top categories of adverse events submitted to the FDA for Desmopressin Acetate, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Desmopressin Acetate is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.